Trupanion (TRUP) Stock Rating Upgraded by BidaskClub
Trupanion (NASDAQ:TRUP) was upgraded by equities research analysts at BidaskClub from a “sell” rating to a “hold” rating in a report issued on Tuesday.
Other analysts also recently issued research reports about the stock. Zacks Investment Research raised shares of Trupanion from a “hold” rating to a “buy” rating and set a $29.00 price target for the company in a research note on Wednesday, October 4th. Canaccord Genuity reissued a “buy” rating and issued a $35.00 price objective (up previously from $29.00) on shares of Trupanion in a research note on Tuesday, October 31st. Finally, CL King started coverage on shares of Trupanion in a research note on Tuesday, November 21st. They issued a “neutral” rating for the company. Three investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. The company has a consensus rating of “Buy” and a consensus target price of $28.83.
Trupanion (NASDAQ TRUP) traded down $0.12 during trading on Tuesday, hitting $29.63. 96,700 shares of the stock traded hands, compared to its average volume of 162,344. The company has a quick ratio of 1.87, a current ratio of 1.87 and a debt-to-equity ratio of 0.15. Trupanion has a 1 year low of $13.71 and a 1 year high of $33.00.
In other news, CFO Tricia Plouf sold 1,000 shares of the company’s stock in a transaction on Tuesday, November 7th. The stock was sold at an average price of $32.11, for a total transaction of $32,110.00. Following the transaction, the chief financial officer now directly owns 14,000 shares of the company’s stock, valued at $449,540. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director Murray B. Low sold 3,000 shares of the company’s stock in a transaction on Tuesday, November 14th. The stock was sold at an average price of $31.14, for a total value of $93,420.00. Following the transaction, the director now directly owns 197,281 shares in the company, valued at $6,143,330.34. The disclosure for this sale can be found here. Insiders sold 118,539 shares of company stock valued at $3,123,783 in the last three months. 31.24% of the stock is currently owned by insiders.
Hedge funds have recently modified their holdings of the company. JPMorgan Chase & Co. acquired a new position in shares of Trupanion during the third quarter worth $143,000. Oppenheimer Asset Management Inc. acquired a new position in shares of Trupanion during the third quarter worth $221,000. Bank of Montreal Can increased its position in shares of Trupanion by 309.2% during the second quarter. Bank of Montreal Can now owns 9,044 shares of the financial services provider’s stock worth $201,000 after purchasing an additional 6,834 shares in the last quarter. Voya Investment Management LLC acquired a new position in shares of Trupanion during the second quarter worth $215,000. Finally, Wells Fargo & Company MN increased its position in shares of Trupanion by 13.5% during the second quarter. Wells Fargo & Company MN now owns 11,261 shares of the financial services provider’s stock worth $252,000 after purchasing an additional 1,342 shares in the last quarter. 63.25% of the stock is currently owned by institutional investors and hedge funds.
Trupanion, Inc provides medical insurance plans for cats and dogs throughout the United States, Canada and Puerto Rico. The Company operates in two business segments: subscription business and other business. The subscription business segment includes monthly subscriptions for its medical plan, which are marketed to consumers.
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.